Introduction
Endometrial remodelling is a prime feature of the menstrual cycle reflecting coordinated changes of shedding and regener¬ ation. The regulatory mechanisms involved in this process are complex and poorly understood. The roles of hormones, cytokines and growth factors have been examined (Finn, 1986; Hunt, 1994; Murphy and Ballejo, 1994; Tabibzadeh, 1991) , but only recently has the role of degradative enzymes become of interest (Marbaix et al, 1992; Martelli et al, 1993; Rodgers et al, 1993 Rodgers et al, , 1994 Hampton and Salamonsen, 1994; Osteen et al, 1994;  Rawdanowicz et al, 1994; Schatz et al, 1994) .
The matrix metalloproteinases are commonly associated with degradative changes in connective tissue elements and have been studied in both physiological and pathological conditions (Matrisian, 1990; Woessner, 1991 (BirkedalHansen et al, 1993; Murphy and Reynolds, 1993) . Gelatinase (92 kDa gelatinase, matrix metalloproteinase-9: MMP-9), degrades a variety of substrates, but particularly collagen types IV and V (Nagase et al, 1991) . It is commonly expressed by macrophages, neutrophils and certain transformed and tumour cells (Morodomi et al, 1992; Jeziorska et al, 1994) and also by human cytotrophoblast from the first trimester (Bischof et al, 1991; Librach et al, 1991) .
Stromelysin 1 is commonly expressed by fibroblastic cells and has a broad spectrum of substrates which include proteo¬ glycans, type IV, IX and X collagene, laminin, fibronectin and large tenascin-C (Okada et al, 1986; Nagase et al, 1991; Wu et al, 1991; Siri et al, 1995) . Since (1994) . The primary antibody was checked for monospecificity and crossreactivity with other purified metalloproteinases (Tetlow et al, 1993; Lees et al, 1994 (Fig. 2) (Fig. 2d') (Aplin, 1991; Aplin et al, 1994) . Since gelatinase secretion is optimal during this peri-implantation phase, it is possible that this enzyme might be functional in processing specific components of the uterine fluid, thereby contributing to the recognition processes required for blastocyst implantation.
The importance of progesterone in the regulation of metalloproteinase expression has been emphasized (Jeffrey et al, 1971; Sato et al, 1991; Marbaix et al, 1992; Martelli et al, 1993; Osteen et al, 1994; Rodgers et al, 1994) . Physiological concentrations of progesterone inhibit the release and activities of collagenase, stromelysins and gelatinases A and by human endometrial expiants (Marbaix et al, 1992; Osteen et al, 1994) and of stromelysin 1 by endometrial stromal and decidual cells (Schatz et al, 1994 (Nagase et al, 1991) and progelatinase (Ogata et al, 1992) . However, at least in the study reported here, there is no evidence that gelatinase and stromelysin 1 occupy the same tissue or secretion environments, other than at menstruation.
Endometrial expression of mRNA for matrilysin and stromelysin-3 were shown to be pronounced during the proliferative, late secretory and menstrual phases, but were not detected during early or mid-secretory endometrium (Rodgers et al, 1993; Osteen et al, 1994 (Rodgers et al, 1993 (Rodgers et al, , 1994 Osteen et al, 1994; Salamonsen et al, 1994) emphasize different functional roles for the matrix metallo¬ proteinases during specific phases of the menstrual cycle. Only during menstruation, with its excessive degradation of the extracellular matrix, are most of the metalloproteinases found in the same tissue location. However, in the late secretory phase and at menstruation, the functionalis contains high numbers of PMNs, monocyte-macrophages and eosinophils (Finn, 1986; Hunt, 1994; Jeziorska et al, 1995) , specific cell types providing not only a source of gelatinase B, but also providing stimulatory factors such as prostanoids and proinflammatory cytokines (Hunt, 1989; Rawdanowicz et al, 1994) which have the potential to promote metalloproteinase expres¬ sion by resident stromal or epithelial cells (Birkedal-Hansen el al, 1993; Murphy and Reynolds, 1993 
